China Class III Hospitals Patient Visit Grows Nearly 14% In First Half Year
This article was originally published in PharmAsia News
China’s National Health and Family Planning Commission released statistics on public healthcare services for the first half of the 2013 fiscal year, outlining clinic visits, payments and hospital stay lengths among other figures.
You may also be interested in...
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.